Quick Answer
Barinthus Biotherapeutics plc. reported Stockholders Equity of $74.21 million for fiscal year 2025.
Barinthus Biotherapeutics plc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $74.21M | -42.9% |
| 2024 | $130.03M | -30.4% |
| 2023 | $186.78M | -23.1% |
| 2022 | $242.90M | -3.7% |
| 2021 | $252.12M | +783.0% |
| 2020 | -$36.91M | -67.2% |
| 2019 | -$22.08M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.47M | -47.0% | -17.5% |
| June 30, 2025 | $102.38M | -34.6% | -11.4% |
| March 31, 2025 | $115.49M | -32.8% | -11.2% |
| December 31, 2024 | $130.03M | -30.4% | -18.4% |
| September 30, 2024 | $159.29M | -18.5% | +1.7% |
| June 30, 2024 | $156.62M | -27.9% | -8.9% |
| March 31, 2024 | $171.83M | -26.3% | -8.0% |
| December 31, 2023 | $186.78M | -23.1% | -4.4% |
- Barinthus Biotherapeutics plc. showed a decrease of -42.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Barinthus Biotherapeutics plc.’s stockholders equity has grown by 436.1% (from -$22.08 million to $74.21 million).
- The most recent figure is from Barinthus Biotherapeutics plc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: